By: Urvi Mahajani
The Maharashtra FDA withdrew its order cancelling Cipla Pharma & Life Sciences Ltd's Pune C&F licence after the Bombay High Court criticised the action as “high-handed”. The court said due process was not followed. FDA told the bench it would issue a fresh show-cause notice and pass a reasoned order after considering Cipla's response fully.













